首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   734篇
  免费   119篇
  国内免费   13篇
儿科学   17篇
妇产科学   5篇
基础医学   128篇
口腔科学   9篇
临床医学   44篇
内科学   143篇
皮肤病学   21篇
神经病学   54篇
特种医学   2篇
外科学   37篇
综合类   32篇
现状与发展   1篇
预防医学   255篇
眼科学   21篇
药学   45篇
中国医学   13篇
肿瘤学   39篇
  2024年   23篇
  2023年   99篇
  2022年   86篇
  2021年   106篇
  2020年   61篇
  2019年   49篇
  2018年   38篇
  2017年   37篇
  2016年   27篇
  2015年   31篇
  2014年   27篇
  2013年   42篇
  2012年   19篇
  2011年   27篇
  2010年   22篇
  2009年   15篇
  2008年   31篇
  2007年   15篇
  2006年   14篇
  2005年   16篇
  2004年   6篇
  2003年   8篇
  2002年   12篇
  2001年   5篇
  2000年   5篇
  1999年   6篇
  1998年   3篇
  1997年   3篇
  1996年   4篇
  1995年   6篇
  1994年   4篇
  1993年   1篇
  1992年   3篇
  1989年   2篇
  1988年   3篇
  1987年   3篇
  1985年   1篇
  1984年   4篇
  1982年   1篇
  1981年   1篇
排序方式: 共有866条查询结果,搜索用时 31 毫秒
101.
尿调节素,又称Tamm-Horsfal蛋白,是由肾小管髓袢升支粗段的小管上皮细胞分泌、也是正常人尿液中含量最多的蛋白。研究发现尿调节素具有多种生物学功能,如调节水盐代谢、调节免疫、防止肾结石产生和防止尿路感染等。近期全基因组关联分析发现编码尿调节素的基因UMOD启动子区单核苷酸多态性与慢性肾病的进展及预后具有很高关联度,并进一步通过孟德尔随机化方法证实尿调节素与慢性肾脏病的因果关系。  相似文献   
102.
Autozygosity mapping (AM) is a technique utilised for mapping homozygous autosomal recessive (AR) traits and facilitation of genetic diagnosis. We investigated the utility of AM for the molecular diagnosis of heterogeneous AR disorders, using epidermolysis bullosa (EB) as a paradigm. We applied this technique to a cohort of 46 distinct EB families using both short tandem repeat (STR) and genome‐wide single nucleotide polymorphism (SNP) array‐based AM to guide targeted Sanger sequencing of EB candidate genes. Initially, 39 of the 46 cases were diagnosed with homozygous mutations using this method. Independently, 26 cases, including the seven initially unresolved cases, were analysed with an EB‐targeted next‐generation sequencing (NGS) panel. NGS identified mutations in five additional cases, initially undiagnosed due to the presence of compound heterozygosity, deep intronic mutations or runs of homozygosity below the set threshold of 2 Mb, for a total yield of 44 of 46 cases (95.7%) diagnosed genetically.  相似文献   
103.
ObjectiveSleep is an essential physiological process that protects our physical and mental health. However, the causality of the association between sleep and coronary heart disease (CHD) is unknown. Mendelian randomization (MR), using genetic variants as instrumental variables to test for causality, can infer credible causal associations. We applied a two-sample MR framework to determine the causal association between sleep (sleeplessness, sleep duration, and daytime dozing) and CHD by integrating summary-level genome-wide association study (GWAS) data.MethodsData included in this study were the GWAS summary statistics datasets from the C4D Consortium for CHD; Neale Lab UKB-a:13 Consortium for sleeplessness; Neale Lab UKB-a:9 Consortium for sleep duration and Neale Lab UKB-a:15 Consortium for daytime dozing. The conventional MR approach (inverse variance weighted, IVW) method and Egger method were used. Heterogeneity was calculated using each of the different MR methods where possible. Horizontal pleiotropy was evaluated by p-value of the MR–Egger intercept.ResultsThe IVW method estimate indicated that the odds ratio (OR) (95% confidence interval, CI) for CHD was 3.924 (1.345–11.447) per standard deviation increase in sleeplessness (p = 0.012). Results were consistent in MR–Egger method (OR, 4.654; 95% CI, 1.191–18.186; p = 0.009). The genetically predicted sleeplessness was positively casually associated with CHD. The causal association between sleep duration (or daytime dozing) and CHD was not established.ConclusionOur analysis provided evidence supporting a causal relationship between sleeplessness (not sleep duration or daytime dozing) and CHD.  相似文献   
104.
BackgroundCausal risk factors for aortic valve stenosis are poorly understood, limiting the possibility of preventing the most common heart valve disease.ObjectivesThe hypothesis was tested that genetically based obesity measured by body mass index is causally associated with risk of aortic valve stenosis and replacement.MethodsThe authors included 108,211 individuals from the Copenhagen General Population Study. Participants had measurements of body mass index, waist-hip ratio, and waist circumference, and information on 5 genetic variants associated with obesity. A Mendelian randomization design was used to investigate genetic and observational associations of obesity with incident aortic valve stenosis (n = 1,215) and replacement (n = 467) for a median follow-up time of 8.7 years.ResultsGenetically increased body mass index was causally associated with increased risk of aortic valve stenosis. Compared with an unweighted allele score of 0 to 3, individuals with an allele score 7 to 10 had a mean increase in body mass index of 0.87 kg/m2, and the age and sex–adjusted hazard ratio for aortic valve stenosis was 1.3 (95% confidence interval [CI]: 1.0 to 1.7) for allele score 4, 1.4 (95% CI: 1.1 to 1.8) for allele score 5 to 6, and 1.6 (95% CI: 1.3 to 2.1) for allele score 7 to 10 (p for trend: 9 × 10−5). A 1-kg/m2 increase in body mass index was associated with causal risk ratios for aortic valve stenosis and replacement, respectively, of 1.52 (95% CI: 1.23 to 1.87) and 1.49 (95% CI: 1.07 to 2.08) genetically, and with corresponding hazard ratios of 1.06 (95% CI: 1.05 to 1.08) and 1.06 (95% CI: 1.03 to 1.08) observationally.ConclusionsObesity from human genetics was causally associated with higher risk of aortic valve stenosis and replacement.  相似文献   
105.
106.
Background and aimsIt is unclear whether the association of childhood obesity with adult atrial fibrillation observed in observational studies reflects causal effects. The aim of this study was to evaluate the association of childhood obesity with adult atrial fibrillation using genetic instruments.Methods and resultsWe used a two-sample Mendelian randomization (MR) design to evaluate the association between childhood obesity and adult atrial fibrillation. Two sets of genetic variants (15 single nucleotide polymorphisms [SNPs] for childhood body mass index [BMI] and 12 SNPs for dichotomous childhood obesity) were selected as instruments. Summary data on SNP-childhood obesity and SNP-atrial fibrillation associations were obtained from recently published genome-wide association studies. Effect estimates were evaluated using inverse-variance weighted (IVW) methods. Other MR analyses, including MR-Egger, simple and weighted median, weighted MBE and MR-PRESSO methods were performed in sensitivity analyses.The IVW models showed that both a genetically predicted one-standard deviation increase in childhood BMI (kg/m2) and higher log-odds of childhood obesity were associated with a substantial increase in the risk of atrial fibrillation (OR = 1.22, 95% CI: 1.11–1.34, P < 0.001; OR = 1.09, 95% CI: 1.04–1.14, P < 0.001). MR-Egger regression showed no evidence of genetic pleiotropy for childhood BMI (intercept = 0.000, 95% CI: ?0.024 to 0.023), but for childhood obesity (intercept = ?0.036, 95% CI: ?0.057 to ?0.015). Similar results were observed using leave-one-out and other MR methods in sensitivity analyses.ConclusionsThis MR analysis found a consistent association between genetically predicted childhood obesity and an increased risk of adult atrial fibrillation. Further research is warranted to validate our findings.  相似文献   
107.
Genetic evidence based on two-sample Mendelian randomization approaches suggested that visceral adipose tissue had a causal, independent role in lowering the risk of Parkinson's disease. Further studies are needed to explore the underlying mechanism.  相似文献   
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号